Anthropic has appointed Vas Narasimhan, CEO of Novartis, to its board of directors, strengthening its leadership in healthcare and AI governance. Vas Narasimhan brings extensive experience in global medicine development, regulatory affairs, and large-scale pharmaceutical innovation. At Novartis, he has overseen the development and approval of more than 35 novel medicines across multiple therapeutic areas.
By Super Admin
|
April
15, 2026